PD-L1 expression, therefore, by regulatory immune cells in the systemic circulation, may disarm cytotoxic T-cells in the tumor periphery in parallel with a similar activity in the tumor microenvironment, and this occurs independently from cancer cell PD-L1-expression status. This evidence concerns the gene CD274 and neoplasm.